Elements TRAMs* is a novel MRI-based methodology for the high resolution depiction of contrast clearance and accumulation, allowing for the differentiation of brain regions with high and low vascular activity
High resolution Treatment Response Assessment Maps (TRAMs) derived from conventional 3D contrast-enhanced MRI data provide additional insights into tumor characteristics and thereby support clinicians during treatment response evaluations. Elements TRAMs serve clinical specialties including radiation oncology, neurosurgery, neuro-oncology and neuroradiology.
Treatment Response Assessment Maps (TRAMs), a novel MRI-based methodology for distinct differentiation of contrast clearance and accumulation, allows for the depiction of brain regions with high (blue) and low (red) vascular activity. The TRAMs methodology was developed at Sheba Medical Center, Tel Aviv, with technology provided by Brainlab.
*CE released, FDA clearance pending.